NMC REGISTRY TEAM:
Top from left:
Carlos Rodriguez-Galindo, Wendy London, James (Jay) Bradner, Chelsey Mitchell, Stephen Sallan, Chris Lathan, Scott Paulson (framed picture).
Bottom from left: Daniel Bauer, Chris French, Kelly Straight.
Clinical Trials are now enrolling NMC patients.
Click HERE for links to these trials.
We welcome any donations. Click HERE to donate via the NMC Registry Giving Page.
Publication reviews: "First clinical proof-of-concept that targeting BRD4-NUT with a BET inhibitor results in rapid antitumor activity in Nut Midline Carcinoma." READ MORE .
SOCIAL MEDIA LINKS:
Like us on Facebook